by Jordana Choucair | Feb 14, 2022 | Life Sciences
The FDA on Friday authorized a new monoclonal antibody treatment to treat mild to moderate COVID-19 symptoms. The drug, developed by Eli Lilly, should be used to treat patients ages 12 and older “for whom alternative COVID-19 treatment options approved or...
by Jordana Choucair | Feb 14, 2022 | Life Sciences
The FDA delayed its decision on authorizing Pfizer-BioNTech’s COVID-19 vaccine for children under five years old. The agency stated, “Based on the agency’s preliminary assessment, and to allow more time to evaluate additional data, we believe additional...
by Jordana Choucair | Feb 14, 2022 | Payers
With Congress eyeing a comprehensive mental health package this year, the health insurance industry is pushing back against a pair of proposals to ramp up enforcement against plans that violate mental health parity laws by regularly denying behavioral health and...
by Jordana Choucair | Feb 14, 2022 | Providers
Multiple states are facing backlogs for health care workers to receive their licenses, keeping them out of the workforce during the COVID-19 pandemic. The delays are contributing to the strain on the country’s health care system. Professional organizations noted...
by Jordana Choucair | Feb 11, 2022 | Opioid/Substance Use Disorders
The CDC released draft updated guidelines for prescribing opioids that would give doctors more flexibility. Guidelines issued in 2016 included specific recommendations, including often limiting opioid prescriptions for acute pain to three days and not exceeding a dose...
by Jordana Choucair | Feb 11, 2022 | Payers
UnitedHealthcare announced it is utilizing technology to make it more convenient for members to access quality, cost-effective dental care. The insurer will enhance its 24/7 virtual dental benefit to provide two free virtual visits with a dentist per year and will...
Recent Comments